HR+/HER2- Ductal Breast Cancer (BC)
1 clinical trials · Condition
◉ Watch HR+/HER2- Ductal Breast Cancer (BC)
| Record | Firm | Date |
|---|---|---|
| Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors (NCT07630961) | Novartis Pharmaceuticals | 2026-06-23 |
Track HR+/HER2- Ductal Breast Cancer (BC) automatically
Every clearance here is in the API, with alerts when new ones post.